Can the outcome of older donor kidneys in transplantation be predicted? An analysis of existing scoring systems

Clinical Transplantation

Volumn 18, Issue 4, 2004, Pages 351-356

  Singh, Dharm ^a   Kiberd, Bryce ^a   Lawen, Joseph ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Marginal donor; Renal; Renal function; Transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CADAVER KIDNEY; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE CLEARANCE; CRYOPRESERVATION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PUBLICATION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RECIPIENT; RETROSPECTIVE STUDY; SCORING SYSTEM; TIME; TREATMENT OUTCOME; VALIDATION PROCESS;

AGE FACTORS; AGED; CREATININE; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE DONORS;

EID: 4043083459     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00201.x     Document Type: Article

References (16)

1. Tullius SG, Volk H-D, Neuhaus P. Transplantation of organs from marginal donors. Transplantation 2001: 72: 1341.
2. Ojo AO, Hanson JA, Meier-Kriesche H et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001: 12: 589.
3. Cameron JS. Renal transplantation in the elderly Age matching. Int Urol Nephrol 2000: 32: 193.
4. Lu AD, Carter JT, Weinstein RJ et al. Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients. Transplantation 2000: 69: 281.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16: 31.
6. Kasiske BL, Andany MA, Hernandez D et al. Comparing methods for monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis 2001: 38: 1065.
7. Nyberg SL, Matas AJ, Rodgers M et al. Donor scoring system for cadaver renal transplantation. Am J Transplantation 2001: 1: 162.
8. Nyberg SL, Matas AJ, Kremers WK et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003: 3: 715.
9. Irish WD, McCollum DA, Tesi RJ et al. Nomogram for predicting delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003: 14: 2967.
10. Remuzzi G, Grinyo J, Ruggenenti P et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double kidney transplant group (DKG). J Am Soc Nephrol 1999: 10: 2591.
11. Karpinski J, Lajoie G, Cattran D et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999: 67: 1162.
12. Wang H, Solez K, Kjellstrand CM, Cockfield SM. The importance of donor vascular pathology in determining renal allograft outcome. J Am Soc Nephrol 1998: 9: 702. (abstract).
13. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997: 63: 968.
14. Pokorna E, Schuck O, Vitko, S, Ekberg H. Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival. Am J Transplantation 2002: 2: 373.
15. Boschiero L, Foroni R, Tonini M, Ancona G. An objective method for detecting time-dependent effects in graft survival. Transpl Int 2000: 13: S 112.
16. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000: 283: 633.